Literature DB >> 25750009

Bicuspid aortic valve disease and ascending aortic aneurysm: should an aortic root replacement be mandatory?†.

Igor Vendramin1, Matteo Meneguzzi2, Sandro Sponga2, Laura Deroma2, Rossella Cimarosti2, Cristina Lutman2, Cristian Daffarra2, Ugolino Livi2.   

Abstract

OBJECTIVES: The higher risk of adverse aortic events in patients with bicuspid aortic valve (BAV) disease and ascending aorta aneurysm is known, but the management of moderate aortic root dilatation in younger patients is a controversial issue. The aim of the study was to compare survival in patients with or without root replacement.
METHODS: We reviewed 166 consecutive patients with BAV disease and concomitant ascending aorta aneurysm (mean ascending aorta diameter: 51.4 ± 7.2 mm) undergoing cardiac surgery from 1994 to 2010. A total of 77 patients underwent Bentall procedure (90.9% male, mean age: 55.7 ± 12.7 years, Bentall group), whereas the remaining 89 patients underwent aortic valve replacement with supracoronary ascending aorta replacement (SAAR 71.9% male, mean age: 60.5 ± 11.2 years, SAAR group, P = 0.002). The preoperative mean diameter of the root was 44.0 ± 7.2 mm in the Bentall, and 38.5 ± 4.8 mm in the SAAR group (P < 0.0001).
RESULTS: In-hospital mortality was 2.6% in the Bentall, and 2.3% in the SAAR groups. Overall survival was 84 and 81% in the Bentall (median follow-up: 105 months) versus 89 and 88% in the SAAR (median follow-up: 73 months) groups at 10 and 15 years (P = 0.36), respectively. The mean cardiopulmonary bypass (CPB) time was 201 ± 56 min and 174 ± 58 min (P = 0.0016), the mean cross-clamp time 156 ± 42 min and 132 ± 38 min (P = 0.0008) in the Bentall and SAAR groups, respectively. Four sudden deaths have occurred in the Bentall group and in 2 in the SAAR group. Progressive dilatation of the aortic root in the SAAR group was not significat (postoperative mean diameter: 36.3 ± 4.4 mm). Neither subgroup of patients in the SAAR with preoperative moderate dilatation of aortic root had significat aortic dilatation at the mean follow-up of 73 ± 39 months (preoperative diameter: 43.5 ± 2.3 mm versus postoperative: 39.1 ± 4.2 mm). One patient in Bentall and 1 in the SAAR groups were reoperated for tubular graft infection.
CONCLUSIONS: In patients with BAV disease, ascending aorta aneurysm and moderate dilatation of the root, the significat reduction of CPB and cross-clamp times, the stability of the residual root at long term and the low risk of adverse aortic events associated with SAAR compared with the Bentall procedure have led us to consider the isolated aortic valve replacement with supracoronary aorta replacement an alternative strategy to the Bentall procedure, especially in high-risk and older patients.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Aortic aneurysm; Aortic root dilatation; Bicuspid aortic valve

Mesh:

Year:  2015        PMID: 25750009     DOI: 10.1093/ejcts/ezv069

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

1.  Surgical Aortic Valve Replacement: Are We Able to Improve Hemodynamic Outcome?

Authors:  Pavlo Yevtushenko; Florian Hellmeier; Jan Bruening; Sarah Nordmeyer; Volkmar Falk; Christoph Knosalla; Marcus Kelm; Titus Kuehne; Leonid Goubergrits
Journal:  Biophys J       Date:  2019-07-22       Impact factor: 4.033

2.  Should sinus of Valsalva be preserved in patients with bicuspid aortic valve and aortic dilation?

Authors:  Yulin Wang; Yi Lin; Kanhua Yin; Kai Zhu; Zhaohua Yang; Yongxin Sun; Hao Lai; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

3.  Dilatation of the initially non-aneurysmal ascending aorta after replacement of a bicuspid versus tricuspid aortic valve.

Authors:  Jing Zhang; Guangpu Fan; Hui Zhao; Xu Wang; Zhiwei Wang; Peide Zhang; Wei Wang
Journal:  J Int Med Res       Date:  2016-08-06       Impact factor: 1.671

4.  Should Sinus of Valsalva be Replaced in Patients with Dilated Ascending Aorta and Aortic Valve Diseases?

Authors:  Salih Salihi; Emir Cantürk; Cengiz Köksal; Hızır Mete Alp
Journal:  Braz J Cardiovasc Surg       Date:  2018 Nov-Dec

5.  Clinical Profile and 30-Day Outcomes of Patients with Bicuspid Aortic Valve Undergoing Aortic Valve and/or Aorta Surgery.

Authors:  Marcelo Kirschbaum; Vitor Emer Egypto Rosa; Brunna Pileggi Azevedo Sampaio; Gabriela Thevenard; Nádia Romanelli Quintanilha; João Ricardo Cordeiro Fernandes; Antonio de Santis; Tarso Duenhas Accorsi; Roney Orismar Sampaio; Flavio Tarasoutchi
Journal:  Arq Bras Cardiol       Date:  2022-03       Impact factor: 2.000

Review 6.  Aortic Dilatation in Patients With Bicuspid Aortic Valve.

Authors:  Jing Wang; Wenhui Deng; Qing Lv; Yuman Li; Tianshu Liu; Mingxing Xie
Journal:  Front Physiol       Date:  2021-07-06       Impact factor: 4.566

7.  Model-Based Therapy Planning Allows Prediction of Haemodynamic Outcome after Aortic Valve Replacement.

Authors:  M Kelm; L Goubergrits; J Bruening; P Yevtushenko; J F Fernandes; S H Sündermann; F Berger; V Falk; T Kuehne; S Nordmeyer
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

8.  Surgical treatment of mild to moderately dilated ascending aorta in bicuspid aortic valve aortopathy: the art of safety and simplicity.

Authors:  Peng Zhu; Pengyu Zhou; Xiao Ling; Bright Eric Ohene; Xiao Ming Bian; Xiaoxiao Jiang
Journal:  J Cardiothorac Surg       Date:  2020-01-17       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.